Combined BRAF and MEK inhibition in BRAF(V600E) mutant melanoma: a synergistic and potentially safe combination partner with immunotherapy

ανά Ott, Patrick A.
Τόπος έκδοσης Ann Transl Med (2015)

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function

ανά Ott, Patrick A., Bhardwaj, Nina
Έκδοση 2013

Small Molecule Protein Kinase Inhibitors and their Effects on the Immune System: Implications for Cancer Treatment

ανά Ott, Patrick A., Adams, Sylvia
Έκδοση 2011

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

ανά Blass, Eryn, Ott, Patrick A.
Τόπος έκδοσης Nat Rev Clin Oncol (2021)

New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy

ανά Luke, Jason J, Ott, Patrick A
Έκδοση 2014

PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma

ανά Luke, Jason J., Ott, Patrick A.
Τόπος έκδοσης Oncotarget (2015)

PD-1 inhibitors in endometrial cancer

ανά Barroso-Sousa, Romualdo, Ott, Patrick A.
Τόπος έκδοσης Oncotarget (2017)

Cancer vaccines: Steering T cells down the right path to eradicate tumors

ανά Ott, Patrick A., Wu, Catherine J.
Τόπος έκδοσης Cancer Discov (2019)

Mucosal Melanomas: A Case-Based Review of the Literature

ανά Seetharamu, Nagashree, Ott, Patrick A., Pavlick, Anna C.
Έκδοση 2010

Towards personalized, tumour-specific, therapeutic vaccines for cancer

ανά Hu, Zhuting, Ott, Patrick A., Wu, Catherine J.
Τόπος έκδοσης Nat Rev Immunol (2017)

The secretory IFN-γ response of single CD4 memory cells after activation on different antigen presenting cell types

ανά Ott, Patrick A., Tary-Lehmann, Magdalena, Lehmann, Paul V.
Έκδοση 2007

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial...

ανά Ott, Patrick A., Hodi, F. Stephen, Buchbinder, Elizabeth I.
Τόπος έκδοσης Front Oncol (2015)

Directing Traffic: How to effectively drive T cells into tumors

ανά Anandappa, Annabelle J., Wu, Catherine J., Ott, Patrick A.
Τόπος έκδοσης Cancer Discov (2020)

HLA-binding properties of tumor neoepitopes in humans

ανά Fritsch, Edward F., Rajasagi, Mohini, Ott, Patrick A., Brusic, Vladimir, Hacohen, Nir, Wu, Catherine J.
Έκδοση 2014

Combination immunotherapy: a road map

ανά Ott, Patrick A., Hodi, F. Stephen, Kaufman, Howard L., Wigginton, Jon M., Wolchok, Jedd D.
Τόπος έκδοσης J Immunother Cancer (2017)

Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies

ανά Dobry, Allison S., Zogg, Cheryl K., Hodi, F. Stephen, Smith, Timothy R., Ott, Patrick A., Iorgulescu, J. Bryan
Τόπος έκδοσης Cancer Immunol Immunother (2018)

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab

ανά Moreira, Raphael B., Hamieh, Lana, Gjini, Evisa, Lako, Ana, Krajewski, Katherine M., Yoon, Charles H., Ott, Patrick A.
Τόπος έκδοσης J Immunother Cancer (2017)

Radiographic Profiling of Immune-related Adverse Events in Advanced Melanoma Patients Treated With Ipilimumab

ανά Tirumani, Sree Harsha, Ramaiya, Nikhil H., Keraliya, Abhishek, Bailey, Nancy D., Ott, Patrick A., Hodi, F. Stephen, Nishino, Mizuki
Τόπος έκδοσης Cancer Immunol Res (2015)

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature

ανά Kumar, Vivek, Shinagare, Atul B., Rennke, Helmut G., Ghai, Sandeep, Lorch, Jochen H., Ott, Patrick A., Rahma, Osama E.
Τόπος έκδοσης Oncologist (2020)

Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma

ανά Luke, Jason J., Donahue, Hilary, Nishino, Mizuki, Giobbie-Hurder, Anita, Davis, Meredith, Bailey, Nancy, Ott, Patrick A., Hodi, F. Stephen
Τόπος έκδοσης Cancer Immunol Res (2015)